Varki Paul

Chief Legal OfficerAvalo Therapeutics, Inc. (AVTX) · full profile →Form 4 · filed May 7, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.5M
Net Open-Market Flow
-$1.5M
Transactions
9
7 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 6, 2026Option exercise(M)63K$13.43$839K66K
May 6, 2026Option exercise(M)13K$8.04$101K79K
May 6, 2026Sell(S)37K$18.91$707K41K
May 6, 2026Sell(S)5K$19.78$103K36K
May 6, 2026Sell(S)23K$21.22$485K13K
May 6, 2026Sell(S)9K$22.70$210K4K
May 6, 2026Sell(S)400$23.71$9K4K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 6, 2026Option exercise(M)63K$088K
May 6, 2026Option exercise(M)13K$087K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001677896-26-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly: